Know Cancer

or
forgot password
  • cancer clinical trials in wyoming

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lymphoma
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Ivinson Memorial Hospital
    Laramie, Wyoming 82070
    Colorectal Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Prostate Cancer
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Multiple Myeloma, Plasma Cell Myeloma
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lymphoma
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Metastatic Cancer, Prostate Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Breast Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Lymphoma
    S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Lymphoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Metastatic Cancer, Prostate Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Bladder Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Prostate Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Leukemia
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Breast Cancer, Metastatic Cancer